The study titled "Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study" (PMID: 17604563) investigated the effects of 600 mg/day alpha-lipoic acid (ALA) supplementation over three months on individuals with peripheral arterial disease (PAD). This randomized controlled trial found that ALA improved walking tolerance and delayed the
